These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 11297257
1. O6-Methylguanine-DNA methyltransferase in pediatric primary brain tumors: relation to patient and tumor characteristics. Bobola MS, Berger MS, Ellenbogen RG, Roberts TS, Geyer JR, Silber JR. Clin Cancer Res; 2001 Mar; 7(3):613-9. PubMed ID: 11297257 [Abstract] [Full Text] [Related]
2. O6-methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics. Silber JR, Bobola MS, Ghatan S, Blank A, Kolstoe DD, Berger MS. Cancer Res; 1998 Mar 01; 58(5):1068-73. PubMed ID: 9500473 [Abstract] [Full Text] [Related]
3. O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy. Silber JR, Blank A, Bobola MS, Ghatan S, Kolstoe DD, Berger MS. Clin Cancer Res; 1999 Apr 01; 5(4):807-14. PubMed ID: 10213216 [Abstract] [Full Text] [Related]
4. Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain. Silber JR, Mueller BA, Ewers TG, Berger MS. Cancer Res; 1993 Jul 15; 53(14):3416-20. PubMed ID: 8324751 [Abstract] [Full Text] [Related]
5. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents. Kokkinakis DM, Ahmed MM, Delgado R, Fruitwala MM, Mohiuddin M, Albores-Saavedra J. Cancer Res; 1997 Dec 01; 57(23):5360-8. PubMed ID: 9393761 [Abstract] [Full Text] [Related]
6. Activity of the DNA repair protein O6-methylguanine-DNA methyltransferase in human tumor and corresponding normal tissue. Preuss I, Haas S, Eichhorn U, Eberhagen I, Kaufmann M, Beck T, Eibl RH, Dall P, Bauknecht T, Hengstler J, Wittig BM, Dippold W, Kaina B. Cancer Detect Prev; 1996 Dec 01; 20(2):130-6. PubMed ID: 8706038 [Abstract] [Full Text] [Related]
7. O6-Methylguanine-DNA methyltransferase protein levels in pediatric brain tumors. Hongeng S, Brent TP, Sanford RA, Li H, Kun LE, Heideman RL. Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2459-63. PubMed ID: 9815647 [Abstract] [Full Text] [Related]
8. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort. Pollack IF, Hamilton RL, Sobol RW, Burnham J, Yates AJ, Holmes EJ, Zhou T, Finlay JL. J Clin Oncol; 2006 Jul 20; 24(21):3431-7. PubMed ID: 16849758 [Abstract] [Full Text] [Related]
9. O6-methylguanine-DNA methyltransferase deficiency in developing brain: implications for brain tumorigenesis. Bobola MS, Blank A, Berger MS, Silber JR. DNA Repair (Amst); 2007 Aug 01; 6(8):1127-33. PubMed ID: 17500046 [Abstract] [Full Text] [Related]
10. O6-methylguanine-DNA methyltransferase in human brain tumors detected by activity assay and monoclonal antibodies. Citron M, White A, Decker R, Wasserman P, Li B, Randall T, Guerra D, Belanich M, Yarosh D. Oncol Res; 1995 Aug 01; 7(1):49-55. PubMed ID: 7549044 [Abstract] [Full Text] [Related]
11. Tetrazepinones are equally cytotoxic to Mer+ and Mer- human tumor cell lines. Jean-Claude BJ, Mustafa A, Watson AJ, Damian Z, Vasilescu D, Chan TH, Leyland-Jones B. J Pharmacol Exp Ther; 1999 Feb 01; 288(2):484-9. PubMed ID: 9918549 [Abstract] [Full Text] [Related]
12. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity. Vassal G, Boland I, Terrier-Lacombe MJ, Watson AJ, Margison GP, Vénuat AM, Morizet J, Parker F, Lacroix C, Lellouch-Tubiana A, Pierre-Kahn A, Poullain MG, Gouyette A. Clin Cancer Res; 1998 Feb 01; 4(2):463-8. PubMed ID: 9516937 [Abstract] [Full Text] [Related]
13. Evaluation of O6-methylguanine DNA methyltransferase activity in patients with gastric cancer. Dinçer Y, Akçay T, Tortum OB, Alademir Z, Onen S, Doğusoy G. Oncol Res; 2003 Feb 01; 13(4):205-9. PubMed ID: 12659421 [Abstract] [Full Text] [Related]
14. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis. Sasai K, Nodagashira M, Nishihara H, Aoyanagi E, Wang L, Katoh M, Murata J, Ozaki Y, Ito T, Fujimoto S, Kaneko S, Nagashima K, Tanaka S. Am J Surg Pathol; 2008 Aug 01; 32(8):1220-7. PubMed ID: 18580490 [Abstract] [Full Text] [Related]
15. Relationship between O6-methylguanine-DNA methyltransferase levels and clinical response induced by chloroethylnitrosourea therapy in glioma patients. Chen ZP, Yarosh D, Garcia Y, Tampieri D, Mohr G, Malapetsa A, Langleben A, Panasci LC. Can J Neurol Sci; 1999 May 01; 26(2):104-9. PubMed ID: 10352868 [Abstract] [Full Text] [Related]
16. [Study on MGMT assay and tumor individual predictable chemotherapy]. Zhang YP. Ai Zheng; 2004 Jun 01; 23(6):724-34. PubMed ID: 15191682 [Abstract] [Full Text] [Related]
17. [Promoter hypermethylation of DNA repair gene O6-methylguanine DNA methyltransferase in laryngeal squamous cell carcinoma]. Zhang S, Kong WJ, Liu Z. Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar 01; 39(3):152-6. PubMed ID: 15283294 [Abstract] [Full Text] [Related]
18. O6-methylguanine-DNA methyltransferase in human normal and tumor tissue from brain, lung, and ovary. Citron M, Decker R, Chen S, Schneider S, Graver M, Kleynerman L, Kahn LB, White A, Schoenhaus M, Yarosh D. Cancer Res; 1991 Aug 15; 51(16):4131-4. PubMed ID: 1868433 [Abstract] [Full Text] [Related]
19. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas. Brell M, Tortosa A, Verger E, Gil JM, Viñolas N, Villá S, Acebes JJ, Caral L, Pujol T, Ferrer I, Ribalta T, Graus F. Clin Cancer Res; 2005 Jul 15; 11(14):5167-74. PubMed ID: 16033832 [Abstract] [Full Text] [Related]
20. Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors. Bello MJ, Alonso ME, Amiñoso C, Anselmo NP, Arjona D, Gonzalez-Gomez P, Lopez-Marin I, de Campos JM, Gutierrez M, Isla A, Kusak ME, Lassaletta L, Sarasa JL, Vaquero J, Casartelli C, Rey JA. Mutat Res; 2004 Oct 04; 554(1-2):23-32. PubMed ID: 15450401 [Abstract] [Full Text] [Related] Page: [Next] [New Search]